Lassen, Ulrik, et al. “A Phase I–II Dose Escalation Study of Fixed-Dose Rate Gemcitabine, Oxaliplatin and Capecitabine Every Two Weeks in Advanced Cholangiocarcinomas”. Acta Oncologica, vol. 50, no. 3, Apr. 2011, pp. 448-54, doi:10.3109/0284186X.2010.500300.